P53 germline mutations and therapy-related myelodysplastic syndrome

Intern Med. 2005 May;44(5):406-7. doi: 10.2169/internalmedicine.44.406.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Genes, p53 / genetics*
  • Genetic Markers
  • Germ-Line Mutation*
  • Humans
  • Mice
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / genetics*

Substances

  • Antineoplastic Agents
  • Genetic Markers